Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Consolidated Net Profit

    Back to Income Statement
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹18 Cr₹-186 Cr₹376 Cr₹835 Cr

What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?

The latest Consolidated Net Profit ratio of PIRAMAL PHARMA is ₹18 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹18 Cr
Mar2023₹-186 Cr
Mar2022₹376 Cr
Mar2021₹835 Cr

How is Consolidated Net Profit of PIRAMAL PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹18 Cr
Positive
Mar2023 ₹-186 Cr
Negative
Mar2022 ₹376 Cr
-54.98
Mar2021 ₹835 Cr -

Compare Consolidated Net Profit of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹27,374.9 Cr 0.4% -0.4% 39.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹399,549.0 Cr -2% -8.4% 14.3% Stock Analytics
DIVIS LABORATORIES ₹175,673.0 Cr -0.2% 7.5% 48% Stock Analytics
CIPLA ₹118,908.0 Cr -0.3% -2.6% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,106.0 Cr -1% -4.1% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,494.0 Cr 0.3% 8% 6.2% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

0.4%

-0.4%

39.9%

SENSEX

-0.4%

0.3%

8.7%


You may also like the below Video Courses